PharmaCielo (TSXV:PCLO) Net Change in Cash : C$-0.37 Mil (TTM As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is PharmaCielo Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

PharmaCielo's Net Change in Cash for the three months ended in Sep. 2023 was C$-0.08 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2023 was C$-0.37 Mil.

PharmaCielo Net Change in Cash Historical Data

The historical data trend for PharmaCielo's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCielo Net Change in Cash Chart

PharmaCielo Annual Data

Trend

Aug17

Aug18

Dec19

Dec20

Dec21

Dec22

Net Change in Cash

Get a 7-Day Free Trial

0.12

-32.08

-4.81

-3.52

-5.17

PharmaCielo Quarterly Data
	Nov18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Net Change in Cash	Get a 7-Day Free Trial															-0.59	-0.23	0.29	-0.36	-0.08

PharmaCielo Net Change in Cash Calculation

PharmaCielo's Net Change in Cash for the fiscal year that ended in Dec. 2022 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-9.708	+	-0.725	+	5.296	+	-0.028
	=	-5.17

PharmaCielo's Net Change in Cash for the quarter that ended in Sep. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.855 + -0.001 + 0.775 + -0.001

= -0.08

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCielo Net Change in Cash Related Terms
Thank you for viewing the detailed overview of PharmaCielo's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaCielo (TSXV:PCLO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaCielo Ltd (TSXV:PCLO) » Definitions » Net Change in Cash

Comparable Companies

XCNQ:TIUM.U TSXV:CANB TSX:LABS TSX:AVCN XCNQ:BNXT TSXV:LSL XCNQ:GDNS XCNQ:GWAY XCNQ:ACRG.A.U TSX:AVNT ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692

Traded in Other Exchanges

PCLOF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmacielo.com

PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of the revenue in the form of the Sale of Cannabis derivative products in Colombia.

Executives

Ian D Atacan Director, Senior Officer

PharmaCielo (TSXV:PCLO) Headlines

No Headlines